Plexus - PLXS Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Plexus in the last twelve months. There are currently 1 sell rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" PLXS shares.
View PLXS analyst ratings or view top-rated stocks.

4 brokers have issued twelve-month price objectives for Plexus' stock. Their PLXS share price forecasts range from $85.00 to $105.00. On average, they expect the company's stock price to reach $95.00 in the next twelve months. This suggests a possible upside of 3.4% from the stock's current price.
View analysts price targets for PLXS or view top-rated stocks among Wall Street analysts.

Plexus' stock was trading at $95.89 at the beginning of 2022. Since then, PLXS stock has decreased by 4.2% and is now trading at $91.86.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 26th 2022.
View our PLXS earnings forecast.

Plexus will be holding an earnings conference call on Thursday, October 27th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

Plexus Corp. (NASDAQ:PLXS) posted its quarterly earnings results on Wednesday, July, 27th. The technology company reported $1.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.10 by $0.23. The technology company earned $981 million during the quarter, compared to analyst estimates of $906.32 million. Plexus had a trailing twelve-month return on equity of 11.79% and a net margin of 3.43%. Plexus's quarterly revenue was up 20.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.99 EPS.

Plexus updated its fourth quarter 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share guidance of $1.19-$1.35 for the period, compared to the consensus earnings per share estimate of $1.19. The company issued revenue guidance of $980.00M-$1.02 billion, compared to the consensus revenue estimate of $941.00 million.

80 employees have rated Plexus Chief Executive Officer Todd Kelsey on Glassdoor.com. Todd Kelsey has an approval rating of 77% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Plexus investors own include Bristol-Myers Squibb (BMY), Pfizer (PFE), Walgreens Boots Alliance (WBA), Berry Global Group (BERY), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM), Teledyne FLIR (FLIR), First Solar (FSLR) and Gilead Sciences (GILD).

Plexus trades on the NASDAQ under the ticker symbol "PLXS."

Shares of PLXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PLXS stock can currently be purchased for approximately $91.86.

Plexus (NASDAQ:PLXS) has a market capitalization of $2.55 billion and generates $3.37 billion in revenue each year. The technology company earns $138.91 million in net income (profit) each year or $4.26 on an earnings per share basis.

The company employs 19,200 workers across the globe.

Plexus' mailing address is One Plexus Way, Neenah WI, 54957. The official website for the company is www.plexus.com. The technology company can be reached via phone at (920) 969-6000, via email at heather.beresford@plexus.com, or via fax at 920-751-5395.